Director, Global Commercial, Cell Therapy, Multiple Myeloma

Role: Global Commercial Director for Multiple Myeloma (MM) Cell Therapy, leading strategic planning, launch, and lifecycle management of the arlo-cel GPRC5D CAR T product and other late-stage MM assets. Responsibilities: develop and execute brand and go-to-market strategies, oversee launch readiness, drive expansion opportunities, and manage cross-functional global alignment; lead commercialization activities including messaging, campaign development, stakeholder engagement, and resource prioritization; partner with regional markets for tailored execution; support strategic decisions on indication expansion and market activation. Qualifications: minimum 10 years in biopharma, with experience in oncology, hematology, or cell therapy preferred; bachelor's degree required, advanced degrees (MBA, MD, PhD, PharmD) preferred; proven success in launching growth brands or indication expansions, ideally within multiple myeloma or cell therapy domains; strong strategic, cross-functional collaboration, and leadership skills; deep industry knowledge, including global drug development and commercialization processes. High-Value: focus on cellular therapies, GPRC5D CAR T, late-stage development, global launch, and lifecycle management within the hematologic malignancies space. Work setup: location flexible with hybrid or onsite requirements, travel not explicitly specified.